MIDD0301 - A first-in-class anti-inflammatory asthma drug targets GABAA receptors without causing systemic immune suppression
MIDD0301 - 首创的抗炎哮喘药物,靶向 GABAA 受体,不会引起全身免疫抑制
期刊:Basic & Clinical Pharmacology & Toxicology
影响因子:2.7
doi:10.1111/bcpt.13206
Nicolas M Zahn, Alec T Huber, Brandon N Mikulsky, Mae E Stepanski, Alexander S Kehoe, Guanguan Li, Melissa Schussman, Mohammed S Rashid Roni, Revathi Kodali, James M Cook, Douglas C Stafford, Douglas A Steeber, Leggy A Arnold